http://202.28.95.4/pharmacy/myfile/Stability%20ATB.pdf WebData on patient/disease characteristics, potential confounders (gastrointestinal/renal impairment, premorbid hypomagnesemia and concomitant medications), dose, electrolytes, and magnesium replacement were collected. Results: Multivariate analysis showed a significant association between hypomagnesemia and treatment duration (P < .001).
Cisplatin Intravenous: Uses, Side Effects, Interactions ... - WebMD
WebCisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, … WebD5W NS LR Abatacept b Aldesleukin a Alemtuzumab c Arsenic trioxide Asparaginase Atropine sulfate Azacitidine Bendamustine Bevacizumab Bleomycin Bortezomib Busulfan Cabazitaxel Carboplatin Cetuximab c Cimetidine Cisplatin Cladribine Cyclophosphamide Cytarabine Cytarabine liposome c Dacarbazine ... phonegrip myigrip
A guide to establishing a hyperthermic intraperitoneal ... - PubMed
WebD5W 5% dextrose in ½ or 1/3normal saline containing 37.5 g mannitol. ADMINISTER:IV Infusion:Give 2 L over 6–8 h INCOMPATIBILITIESSolution/additive:5% dextrose,fluorouracil,mesna,metoclopramide,sodium bicarbonate,thiotepa. WebJan 15, 2007 · Cisplatin NS 0.05 - 1 mg/mL 250 - 500 mL 1-2 hours Hydration; Do not refrigerate; Cladrabine NS 500 - 1000 mL 2 hours, CIVI Usually given as 7 day CIVI … WebIV in D5W to a total volume of 240 mL by continuous infusion at 2 mL/h via appropriate infusor device* ... Renal dysfunction: for CISplatin . Calculated Cr Clearance (mL/min) by Cockcroft/Gault formula CISplatin dose greater than or equal to 60 . … how do you spell solitary